Skip to main content
. 2022 Sep 10;26(1):193–196. doi: 10.1007/s10456-022-09855-4

Fig. 1.

Fig. 1

Attenuation of liver cirrhosis and portal hypertension by the combination treatment. Typical cirrhotic appearance with extensive nodular formation (a) and fibrotic septa (b) was presented in livers of the TAA group. These hepatic nodules and fibrotic septa (Masson’s trichrome staining, × 100 magnifications) were almost not observed in the TAA + combination group. The fibrotic areas (c) and hepatic α-SMA (d) and collagen III (e) mRNA quantified by quantitative real-time PCR (qRT-PCR) also decreased in the TAA + combination group. Mean arterial pressure (f) and heart rate (g) were comparable in three groups. Portal pressure in the TAA group was the highest among three groups (h). *p < 0.05 versus control group; #p < 0.05 versus TAA group